SAN RAMON, CA--(Marketwired - May 12, 2015) -
Highlighted Links |
Nextrials, Inc. |
most innovative platforms |
"Currently, the average length of time to develop a drug ranges from 10 to 15 years," said Nextrials CEO Jim Rogers. "The costs associated with clinical trials are very steep, so delivering relevant patient data to researchers in a cleaner and faster manner saves money and speeds the decision making process. Integration with electronic health records is key to achieving these goals."
Prism has now earned multiple industry awards, including the Society of Clinical Data Management's Innovation Award, and offers pharmaceutical, biotech and medical device researchers an important step forward in achieving complete interoperability of their systems.
To learn more about Nextrials' E2E tool and the complete Prism platform, please click here.
About Nextrials
Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,500 research sites to streamline the initiation and management of clinical trials. Nextrials has achieved the status of Registered Solutions Provider with the Clinical Data Interchange Standards Consortium (CDISC) for its integration with electronic health records (EHR). The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com or call 925-355-3000.
Help employers find you! Check out all the jobs and post your resume.